Bacitracin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

35 API Suppliers, 22 USDMF, 5 CEP/COS, 2 JDMF, 15 NDC API, 1 VMF, 13 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

66 FDF Dossiers, 39 FDA Orange Book, 4 Europe, 17 Canada, 2 South Africa, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, OINTMENT;OPHTHALMIC - EQ 400 UNITS/GM;EQ 3.5MG BASE/GM;EQ 10,000 UNITS/GM

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 DKSH, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 10 Actylis, 11 BASF, 1 Finar, 5 Gangwal Chemicals, 4 Kerry, 2 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 1 Pluviaendo, 5 Roquette, 7 Seppic

EXCIPIENTS BY APPLICATIONS

18 Topical, 15 Solubilizers, 12 Parenteral, 9 Coating Systems & Additives, 8 Thickeners and Stabilizers, 8 Film Formers & Plasticizers, 6 Emulsifying Agents, 5 Co-Processed Excipients, 5 Direct Compression, 4 Surfactant & Foaming Agents, 3 Fillers, Diluents & Binders, 3 Granulation, 3 Lubricants & Glidants, 2 Taste Masking, 2 Controlled & Modified Release, 1 Rheology Modifiers, 1 API Stability Enhancers

DIGITAL CONTENT

11 NEWS #PharmaBuzz

11 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

5 Finished Drug Prices

5 Finished Drug Prices

MARKET PLACE

21 APIs, 1 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 1 Others

$ Xls

Filters

Digital Content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Pharmexcil announces strategic pharma cooperation between India and Taiwan

03 Jun 2024

// PHARMABIZ

Enforcement Report - Week of June 7, 2023

07 Jun 2023

// FDA

Enforcement Report - Week of January 25, 2023

25 Jan 2023

// FDA

Orofino Pharmaceuticals Group (OPG) consists of a range of companies specialized in third-party manufacturing services.

31 Oct 2020

// PRESS RELEASE

FDA requests withdrawal of bacitracin for injection from market

01 Feb 2020

// FDA

FDA requests withdrawal of bacitracin for injection from market

31 Jan 2020

// RAPS

Bacitracin

Bacitracin

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

35 API Suppliers

22 USDMF

5 CEP/COS

2 JDMF

15 NDC API

1 VMF

13 Listed Suppliers

$ API Reference Price

FINISHED DOSAGE FORMULATIONS

66 FDF Dossiers

39 FDA Orange Book

4 Europe

17 Canada

2 South Africa

4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

OINTMENT;OPHTHALMIC - EQ 400 UNITS/GM;EQ 3.5MG BASE/GM;EQ 10,000 UNITS/GM

RELATED EXCIPIENT COMPANIES

1 SPI Pharma

1 DKSH

3 Nanjing Well Pharmaceutical

1 Pfanstiehl

10 Actylis

11 BASF

1 Finar

5 Gangwal Chemicals

4 Kerry

2 Microlex e.U

1 Nanjing Bold Chemical

2 Nippon Fine Chemical

1 Pluviaendo

5 Roquette

7 Seppic

EXCIPIENTS BY APPLICATIONS

18 Topical

15 Solubilizers

12 Parenteral

9 Coating Systems & Additives

8 Thickeners and Stabilizers

8 Film Formers & Plasticizers

6 Emulsifying Agents

5 Co-Processed Excipients

5 Direct Compression

4 Surfactant & Foaming Agents

3 Fillers, Diluents & Binders

3 Granulation

3 Lubricants & Glidants

2 Taste Masking

2 Controlled & Modified Release

1 Rheology Modifiers

1 API Stability Enhancers

DIGITAL CONTENT

11 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

5 Finished Drug Prices

MARKET PLACE

21 APIs

1 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 EDQM

1 USP

1 Others

Filters

OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons